Missed postoperative metabolic acidosis associated with sodium-glucose transporter 2 inhibitors in cardiac surgery patients: a retrospective analysis
Abstract The increasing use of sodium glucose transporter 2 inhibitors (SGLT2i) for treating cardiovascular (CV) diseases and type 2 diabetes (T2D) is accompanied by a rise in euglycemic diabetic ketoacidosis occurrences in cardiac surgery patients. Patients undergoing cardiac surgery, due to their...
Main Authors: | Hyeon A Kim, Joo Yeon Kim, Young Hwan Kim, Young Tak Lee, Pyo Won Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-58853-7 |
Similar Items
-
Case of hyperosmolar hyperglycemic state by a sodium-glucose cotransporter 2 inhibitor
by: In-Young Nho, et al.
Published: (2018-12-01) -
Sodium bicarbonate as prevention of metabolic acidosis in sheep submitted to experimental ruminal acidosis
by: Luciane M. Laskoski, et al.
Published: (2014-09-01) -
Sodium-hydrogen exchange and its role in controlling contractility during acidosis in cardiac muscle.
by: Vaughan-Jones, R, et al.
Published: (1989) -
Impact of Sodium–Glucose Co-Transporter 2 Inhibitors on Cardiac Protection
by: Victor Chien-Chia Wu, et al.
Published: (2021-07-01) -
Metabolomic profiling in kidney cells treated with a sodium glucose-cotransporter 2 inhibitor
by: Hyung Ah Jo, et al.
Published: (2023-02-01)